SACT protocols
Although these pages are public, the chemotherapy information within them is for Cancer Alliance staff and therefore the language may appear confusing to those who do not work in this area.
Disclaimer:
The SACT protocols available on this website are maintained by the Lancashire and South Cumbria network pharmacist David Barber. The Cancer Alliance is not responsible for the content or upkeep of the protocols. If you have any queries about the protocols please contact David Barber: Tel 01772 522339 or david.barber@lthtr.nhs.uk
For the management of acute oncology and immunotherapy toxicities please visit the acute oncology CRG page via the below link:
Cancer Alliance Clinical Trials- (Summaries for out of hours)
Amplitude - Clinical trials summary for out of hours
AURORA Study - Clinical trials summary for out of hours
BNT113-01- Clinical trials summary for out of hours
BNT122-01 - Clinical trials summary for out of hours
BNT327-01 - Clinical trials summary for out of hours
Checkmate 848 Solid Tumour Trial CA209848 - Clinical trials summary for out of hours
Couplet - Clinical trials summary for out of hours- Phase 1b V 1 10-10-18 (October 2018)
DECIPHER- Clinical trials summary for out of hours
HeredERA - Clinical trials summary for out of hours
Imvigor011 - Clinical trials summary for out of hours
lidERA (GO42784) - Clinical trials summary for out of hours
MK3475-992_IRAS 1003217_Clinical trials summary for out of hours
MK3475-U03 - Clinical trials summary for out of hours
MK5684_004 OMAHA Study - Clinical trials summary for out of hours
MK5684-01a - Clinical trials summary for out of hours
MODIFY MODI1 - Clinical trials summary for out of hours
MORAb - 202-G000-20 - Clinical trials summary for out of hours
POD1UM303 - Clinical trials summary for out of hours
SCOPE Study- Clinical trials summary for out of hours
TROPION Lung-10 - Clinical trials summary for out of hours.pdf
WO43919 - INAVO121 IRAS 1007071 - Clinical trials Summary for out of hours